A functional comparison of canine and murine bone marrow derived cultured mast cells

Veterinary Immunology and Immunopathology

Volumn 114, Issue 3-4, 2006, Pages 320-334

  Lin, Tzu Yin ^a   London, Cheryl A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Chemokine; Cytokine; Dog; Mast cell; Mouse

Indexed keywords

CHEMOKINE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TRYPTASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL DAMAGE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CROSS LINKING; DOG; MAST CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BONE MARROW CELLS; CELL DEGRANULATION; CELL PROLIFERATION; CHEMOKINES; DOGS; FEMALE; IMMUNOGLOBULIN E; MALE; MAST CELLS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TOLL-LIKE RECEPTORS; TRYPTASES;

CANIS FAMILIARIS; MURINAE;

EID: 33750314794     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.09.001     Document Type: Article

References (61)

1. Auchampach J.A., Jin X., Wan T.C., Caughey G.H., and Linden J. Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. Mol. Pharmacol. 52 (1997) 846-860
2. Bidri M., Vouldoukis I., Mossalayi M.D., Debre P., Guillosson J.J., Mazier D., and Arock M. Evidence for direct interaction between mast cells and Leishmania parasites. Parasite Immunol. 19 (1997) 475-483
3. Bischoff S.C., and Sellge G. Mast cell hyperplasia: role of cytokines. Int. Arch. Allergy Immunol. 127 (2002) 118-122
4. Bouton L.A., Ramirez C.D., Bailey D.P., Yeatman C.F., Yue J., Wright H.V., Domen J., Rosato R.R., Grant S., Fischer-Stenger K., and Ryan J.J. Costimulation with interleukin-4 and interleukin-10 induces mast cell apoptosis and cell-cycle arrest: the role of p53 and the mitochondrion. Exp. Hematol. 32 (2004) 1137-1145
5. Brazis P., Queralt M., de Mora F., Ferrer L., and Puigdemont A. Comparative study of histamine release from skin mast cells dispersed from atopic, ascaris-sensitive and healthy dogs. Vet. Immunol. Immunopathol. 66 (1998) 43-51
6. Brazis P., Queralt M., de Mora F., Ferrer L.I., and Puigdemont A. Stem cell factor enhances IgE-mediated histamine and TNF-alpha release from dispersed canine cutaneous mast cells. Vet. Immunol. Immunopathol. 75 (2000) 97-108
7. Cho N.H., Seong S.Y., Huh M.S., Han T.H., Koh Y.S., Choi M.S., and Kim I.S. Expression of chemokine genes in murine macrophages infected with Orientia tsutsugamushi. Infect. Immun. 68 (2000) 594-602
8. Conti P., Kempuraj D., Di Gioacchino M., Boucher W., Letourneau R., Kandere K., Barbacane R.C., Reale M., Felaco M., Frydas S., and Theoharides T.C. Interleukin-6 and mast cells. Allergy Asthma Proc. 23 (2002) 331-335
9. D'Andrea M.R., Derian C.K., Santulli R.J., and Andrade-Gordon P. Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues. Am. J. Pathol. 158 (2001) 2031-2041
10. Dahl C., Saito H., Nielsen H.V., and Schiotz P.O. The establishment of a combined serum-free and serum-supplemented culture method of obtaining functional cord blood-derived human mast cells. J. Immunol. Meth. 262 (2002) 137-143
11. de Mora F., Garcia G., Ferrer L., and Arboix M. Canine cutaneous mast cells dispersion and histamine secretory characterization. Vet. Immunol. Immunopathol. 39 (1993) 421-429
12. Diaz B.L., Fujishima H., Kanaoka Y., Urade Y., and Arm J.P. Regulation of prostaglandin endoperoxide synthase-2 and IL-6 expression in mouse bone marrow-derived mast cells by exogenous but not endogenous prostanoids. J. Immunol. 168 (2002) 1397-1404
13. Fang K.C., Raymond W.W., Blount J.L., and Caughey G.H. Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J. Biol. Chem. 272 (1997) 25628-25635
14. Fang K.C., Raymond W.W., Lazarus S.C., and Caughey G.H. Dog mastocytoma cells secrete a 92-kDa gelatinase activated extracellularly by mast cell chymase. J. Clin. Invest. 97 (1996) 1589-1596
15. Fang K.C., Wolters P.J., Steinhoff M., Bidgol A., Blount J.L., and Caughey G.H. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. J. Immunol. 162 (1999) 5528-5535
16. Fujimoto T., Sato Y., Sasaki N., Teshima R., Hanaoka K., and Kitani S. The canine mast cell activation via CRP. Biochem. Biophys. Res. Commun. 301 (2003) 212-217
17. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6 (2005) 135-142
18. Garcia G., Brazis P., Majo N., Ferrer L., de Mora F., and Puigdemont A. Comparative morphofunctional study of dispersed mature canine cutaneous mast cells and BR cells, a poorly differentiated mast cell line from a dog subcutaneous mastocytoma. Vet. Immunol. Immunopathol. 62 (1998) 323-337
19. Gebhardt T., Lorentz A., Detmer F., Trautwein C., Bektas H., Manns M.P., and Bischoff S.C. Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1. Gut 54 (2005) 928-934
20. Gerritsen R.J., Teske E., Kraus J.S., and Rutteman G.R. Multi-agent chemotherapy for mast cell tumours in the dog. Vet. Quart. 20 (1998) 28-31
21. Gomez G., Ramirez C.D., Rivera J., Patel M., Norozian F., Wright H.V., Kashyap M.V., Barnstein B.O., Fischer-Stenger K., Schwartz L.B., Kepley C.L., and Ryan J.J. TGF-beta 1 inhibits mast cell Fc epsilon RI expression. J. Immunol. 174 (2005) 5987-5993
22. Imlach W., McCaughan C.A., Mercer A.A., Haig D., and Fleming S.B. Orf virus-encoded interleukin-10 stimulates the proliferation of murine mast cells and inhibits cytokine synthesis in murine peritoneal macrophages. J. Gen. Virol. 83 (2002) 1049-1058
23. Kaplan A.P. Chemokines, chemokine receptors and allergy. Int. Arch. Allergy Immunol. 124 (2001) 423-431
24. Kikuchi T., Ishida S., Kinoshita T., Sakuma S., Sugawara N., Yamashita T., and Koike K. IL-6 enhances IgE-dependent histamine release from human peripheral blood-derived cultured mast cells. Cytokine 20 (2002) 200-209
25. Kinoshita T., Sawai N., Hidaka E., Yamashita T., and Koike K. Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34(+) cord blood cells. Blood 94 (1999) 496-508
26. Kulka M., and Metcalfe D.D. High-resolution tracking of cell division demonstrates differential effects of TH1 and TH2 cytokines on SCF-dependent human mast cell production in vitro: correlation with apoptosis and Kit expression. Blood 105 (2005) 592-599
27. Larsen A.E., and Grier R.L. Evaluation of canine mast cell tumors for presence of estrogen receptors. Am. J. Vet. Res. 50 (1989) 1779-1780
28. Leibman N.F., Lana S.E., Hansen R.A., Powers B.E., Fettman M.J., Withrow S.J., and Ogilvie G.K. Identification of matrix metalloproteinases in canine cutaneous mast cell tumors. J. Vet. Intern. Med. 14 (2000) 583-586
29. Liao A.T., Chien M.B., Shenoy N., Mendel D.B., McMahon G., Cherrington J.M., and London C.A. Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors. Blood 100 (2002) 585-593
30. Lin, T.Y., Rush, L.J., London, C.A., 2006. Generation and characterization of bone marrow-derived cultured canine mast cells. Vet. Immunol. Immunopathol.
31. London C.A., and Seguin B. Mast cell tumors in the dog. Vet. Clin. North Am. Small Anim. Pract. 33 (2003) 473-489 v
32. Marshall J.S., and Jawdat D.M. Mast cells in innate immunity. J. Allergy Clin. Immunol. 114 (2004) 21-27
33. Masini E., Planchenault J., Pezziardi F., Gautier P., and Gagnol J.P. Histamine-releasing properties of polysorbate 80 in vitro and in vivo: correlation with its hypotensive action in the dog. Agents Actions 16 (1985) 470-477
34. Mekori Y.A., Oh C.K., and Metcalfe D.D. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J. Immunol. 151 (1993) 3775-3784
35. Mirmonsef P., Shelburne C.P., Fitzhugh Yeatman II C., Chong H.J., and Ryan J.J. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3′-kinase. J. Immunol. 163 (1999) 2530-2539
36. Misdorp W. Mast cells and canine mast cell tumours. A review. Vet. Quart. 26 (2004) 156-169
37. Nabeshima Y., Hiragun T., Morita E., Mihara S., Kameyoshi Y., and Hide M. IL-4 modulates the histamine content of mast cells in a mast cell/fibroblast co-culture through a Stat6 signaling pathway in fibroblasts. FEBS Lett. 579 (2005) 6653-6658
38. Noguchi J., Kuroda E., and Yamashita U. Strain difference of murine bone marrow-derived mast cell functions. J. Leukoc. Biol. 78 (2005) 605-611
39. Noli C., and Miolo A. The mast cell in wound healing. Vet. Dermatol. 12 (2001) 303-313
40. Norozian F., Kashyap M., Ramirez C.D., Patel N., Kepley C.L., Barnstein B.O., and Ryan J.J. TGFbeta1 induces mast cell apoptosis. Exp. Hematol. 34 (2006) 579-587
41. Overbergh L., Giulietti A., Valckx D., Decallonne R., Bouillon R., and Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J. Biomol. Tech. 14 (2003) 33-43
42. Pennington D.W., Lopez A.R., Thomas P.S., Peck C., and Gold W.M. Dog mastocytoma cells produce transforming growth factor beta 1. J. Clin. Invest. 90 (1992) 35-41
43. Price K.S., and Castells M.C. Taxol reactions. Allergy Asthma Proc. 23 (2002) 205-208
44. Puxeddu I., Piliponsky A.M., Bachelet I., and Levi-Schaffer F. Mast cells in allergy and beyond. Int. J. Biochem. Cell Biol. 35 (2003) 1601-1607
45. Robbie-Ryan M., Tanzola M.B., Secor V.H., and Brown M.A. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J. Immunol. 170 (2003) 1630-1634
46. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol. Immunol. 38 (2002) 881-885
47. Rose Jr. C.E., Sung S.S., and Fu S.M. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 10 (2003) 273-288
48. Ryan J.J., DeSimone S., Klisch G., Shelburne C., McReynolds L.J., Han K., Kovacs R., Mirmonsef P., and Huff T.F. IL-4 inhibits mouse mast cell Fc epsilonRI expression through a STAT6-dependent mechanism. J. Immunol. 161 (1998) 6915-6923
49. Sato Y., Teshima R., Nakamura R., Takagi K., Sasaki N., Sawada J., and Kitani S. Canine mast cell activation via human IgG1 and IgG4. Int. Arch. Allergy Immunol. 135 (2004) 154-160
50. Schramm R., and Thorlacius H. Neutrophil recruitment in mast cell-dependent inflammation: inhibitory mechanisms of glucocorticoids. Inflamm. Res. 53 (2004) 644-652
51. Schwartz L.B. Tryptase, a mediator of human mast cells. J. Allergy Clin. Immunol. 86 (1990) 594-598
52. Shakoory B., Fitzgerald S.M., Lee S.A., Chi D.S., and Krishnaswamy G. The role of human mast cell-derived cytokines in eosinophil biology. J. Interferon. Cytokine Res. 24 (2004) 271-281
53. Shimizu Y., Sakai K., Miura T., Narita T., Tsukagoshi H., Satoh Y., Ishikawa S., Morishita Y., Takai S., Miyazaki M., Mori M., Saito H., Xia H., and Schwartz L.B. Characterization of 'adult-type' mast cells derived from human bone marrow CD34(+) cells cultured in the presence of stem cell factor and interleukin-6. Interleukin-4 is not required for constitutive expression of CD54, Fc epsilon RI alpha and chymase, and CD13 expression is reduced during differentiation. Clin. Exp. Allergy 32 (2002) 872-880
54. Stassen M., Arnold M., Hultner L., Muller C., Neudorfl C., Reineke T., and Schmitt E. Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1. J. Immunol. 164 (2000) 5549-5555
55. Szalai C., Kozma G.T., Nagy A., Bojszko A., Krikovszky D., Szabo T., and Falus A. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J. Allergy Clin. Immunol. 108 (2001) 375-381
56. Takahashi T., Kitani S., Nagase M., Mochizuki M., Nishimura R., Morita Y., and Sasaki N. IgG-mediated histamine release from canine mastocytoma-derived cells. Int. Arch. Allergy Immunol. 125 (2001) 228-235
57. Teran L.M., Noso N., Carroll M., Davies D.E., Holgate S., and Schroder J.M. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J. Immunol. 157 (1996) 1806-1812
58. Theoharides T.C., and Conti P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol. 25 (2004) 235-241
59. VanSaun M.N., and Matrisian L.M. Matrix metalloproteinases and cellular motility in development and disease. Birth Defects Res. C: Embryo Today 78 (2006) 69-79
60. von Ruedorffer U., Fisch R., Peel J., Roosje P., Griot-Wenk M., and Welle M. Flea bite hypersensitivity: new aspects on the involvement of mast cells. Vet. J. 165 (2003) 149-156
61. Yang S., Boroughs K.L., and McDermott M.J. Canine interleukin-13: molecular cloning of full-length cDNA and expression of biologically active recombinant protein. J. Interferon Cytokine Res. 20 (2000) 779-785